These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12723248)

  • 1. Outpatient and home parenteral antibiotic therapy (OHPAT) in low-risk febrile neutropenia: consensus statement of a Belgian panel.
    Beguin Y; Benoit Y; Crokaert F; Selleslag D; Vandercam B;
    Acta Clin Belg; 2002; 57(6):309-16. PubMed ID: 12723248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of an outpatient and home parenteral antibiotic therapy (OHPAT) programme in Tayside, Scotland.
    Seaton RA; Nathwani D; Williams FL; Boyter AC
    J Infect; 1999 Sep; 39(2):129-33. PubMed ID: 10609530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of an outpatient and home parenteral antimicrobial therapy service at a London teaching hospital: a case series.
    Hitchcock J; Jepson AP; Main J; Wickens HJ
    J Antimicrob Chemother; 2009 Sep; 64(3):630-4. PubMed ID: 19549671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outpatient and home parenteral antibiotic therapy (OHPAT) in the UK: survey of infection specialists' experience and views.
    Seaton RA; Nathwani D
    Clin Microbiol Infect; 2000 Jul; 6(7):387-90. PubMed ID: 11168156
    [No Abstract]   [Full Text] [Related]  

  • 5. The outpatient management of febrile neutropenia in cancer patients.
    Freifeld AG; Pizzo PA
    Oncology (Williston Park); 1996 Apr; 10(4):599-606, 611-2; discussion 615-6. PubMed ID: 8723296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Out-patient and home-parenteral antibiotic therapy (OHPAT): evaluation of the impact of one year's experience in Tayside.
    Nathwani D; Morrison J; Seaton RA; France AJ; Davey P; Gray K
    Health Bull (Edinb); 1999 Sep; 57(5):332-7. PubMed ID: 12811880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Possibilities and limits of ambulatory supportive measures in oncology exemplified by antibiotic therapy of febrile neutropenia].
    Karthaus M; Meran JG; Geissler RG; Böhme A; Jürgens H; Ganser A
    Wien Med Wochenschr; 1998; 148(18):427-32. PubMed ID: 9888179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of various antibiotic combinations for the empiric treatment of neutropenic febrile children.
    Anak S; Devecioğlu O; Ağaoğlu L; Zülfikar B; Ayan I; Atilgan N; Yalman N; Bilgen H; Kaya G; Gedikoğlu G
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():104. PubMed ID: 2697388
    [No Abstract]   [Full Text] [Related]  

  • 9. Medical and non-medical barriers to outpatient treatment of fever and neutropenia in children with cancer.
    Quezada G; Sunderland T; Chan KW; Rolston K; Mullen CA
    Pediatr Blood Cancer; 2007 Mar; 48(3):273-7. PubMed ID: 16435377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proceedings of the 4th International Symposium on Febrile Neutropenia. December 15-17, 1999.
    Int J Antimicrob Agents; 2000 Oct; 16(2):83-187. PubMed ID: 11203263
    [No Abstract]   [Full Text] [Related]  

  • 11. Ceftriaxone in febrile neutropenia.
    Karthaus M; Cornely OA
    J Chemother; 2003 Jun; 15(3):211-9. PubMed ID: 12868545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled trial comparing oral amoxicillin-clavulanate and ofloxacin with intravenous ceftriaxone and amikacin as outpatient therapy in pediatric low-risk febrile neutropenia.
    Gupta A; Swaroop C; Agarwala S; Pandey RM; Bakhshi S
    J Pediatr Hematol Oncol; 2009 Sep; 31(9):635-41. PubMed ID: 19684522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outpatient treatment with intravenous antimicrobial therapy and oral levofloxacin in patients with febrile neutropenia and hematological malignancies.
    Bellesso M; Costa SF; Pracchia LF; Santos Dias LC; Chamone D; Dorlhiac-Llacer PE
    Ann Hematol; 2011 Apr; 90(4):455-62. PubMed ID: 20852999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outpatient parenteral antibiotic therapy for fever and neutropenia.
    Tice AD
    Infect Dis Clin North Am; 1998 Dec; 12(4):963-77, viii. PubMed ID: 9888033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outpatient antibiotic therapy for febrile episodes in low-risk neutropenic patients with cancer.
    Escalante CP; Rubenstein EB; Rolston KV
    Cancer Invest; 1997; 15(3):237-42. PubMed ID: 9171858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inpatient versus outpatient management of low-risk pediatric febrile neutropenia: measuring parents' and healthcare professionals' preferences.
    Sung L; Feldman BM; Schwamborn G; Paczesny D; Cochrane A; Greenberg ML; Maloney AM; Hendershot EI; Naqvi A; Barrera M; Llewellyn-Thomas HA
    J Clin Oncol; 2004 Oct; 22(19):3922-9. PubMed ID: 15459214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early hospital discharge with oral antimicrobial therapy in patients with hematologic malignancies and low-risk febrile neutropenia.
    Girmenia C; Russo E; Carmosino I; Breccia M; Dragoni F; Latagliata R; Mecarocci S; Morano SG; Stefanizzi C; Alimena G
    Ann Hematol; 2007 Apr; 86(4):263-70. PubMed ID: 17225113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Imipenem combined with teicoplanin or vancomycin in the initial empirical treatment of febrile neutropenia. Analysis of the primary response and of a global sequential strategy in 126 episodes].
    Figuera A; Tomás JF; Hernández L; Jiménez ML; Peñarrubia MJ; del Rey MC; Arranz R; Cámara R; López-Lorenzo JL; Fernández-Rañada JM
    Rev Clin Esp; 1996 Aug; 196(8):515-22. PubMed ID: 8984537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina.
    Paganini H; Gómez S; Ruvinsky S; Zubizarreta P; Latella A; Fraquelli L; Iturres AS; Casimir L; Debbag R
    Cancer; 2003 Apr; 97(7):1775-80. PubMed ID: 12655535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New trends in patient management: risk-based therapy for febrile patients with neutropenia.
    Rolston KV
    Clin Infect Dis; 1999 Sep; 29(3):515-21. PubMed ID: 10530438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.